Research ArticleHuman Studies
Prediction of Radiation Doses from Therapy Using Tracer Studies with Iodine-131-Labeled Antibodies
Diane A. DeNardo, Gerald L. DeNardo, Aina Yuan, Sui Shen, Sally J. DeNardo, Daniel J. Macey, Kathleen R. Lamborn, Marc Mahe, Mark W. Groch and William D. Erwin
Journal of Nuclear Medicine December 1996, 37 (12) 1970-1975;
Diane A. DeNardo
Gerald L. DeNardo
Aina Yuan
Sui Shen
Sally J. DeNardo
Daniel J. Macey
Kathleen R. Lamborn
Marc Mahe
Mark W. Groch


This is a PDF-only article. The first page of the PDF of this article appears above.
In this issue
Prediction of Radiation Doses from Therapy Using Tracer Studies with Iodine-131-Labeled Antibodies
Diane A. DeNardo, Gerald L. DeNardo, Aina Yuan, Sui Shen, Sally J. DeNardo, Daniel J. Macey, Kathleen R. Lamborn, Marc Mahe, Mark W. Groch, William D. Erwin
Journal of Nuclear Medicine Dec 1996, 37 (12) 1970-1975;
Prediction of Radiation Doses from Therapy Using Tracer Studies with Iodine-131-Labeled Antibodies
Diane A. DeNardo, Gerald L. DeNardo, Aina Yuan, Sui Shen, Sally J. DeNardo, Daniel J. Macey, Kathleen R. Lamborn, Marc Mahe, Mark W. Groch, William D. Erwin
Journal of Nuclear Medicine Dec 1996, 37 (12) 1970-1975;
Jump to section
Related Articles
- No related articles found.
Cited By...
- Tumor-Absorbed Dose for Non-Hodgkin Lymphoma Patients Treated with the Anti-CD37 Antibody Radionuclide Conjugate 177Lu-Lilotomab Satetraxetan
- Myeloablative 131I-Tositumomab Radioimmunotherapy in Treating Non-Hodgkin's Lymphoma: Comparison of Dosimetry Based on Whole-Body Retention and Dose to Critical Organ Receiving the Highest Dose
- Model-Based Versus Patient-Specific Dosimetry: Blurring the Lines
- An Activity Quantification Method Based on Registration of CT and Whole-Body Scintillation Camera Images, with Application to 131I
- 67Cu- versus131I-Labeled Lym-1 Antibody: Comparative Pharmacokinetics and Dosimetry in Patients with Non-Hodgkin's Lymphoma